253 related articles for article (PubMed ID: 21368587)
1. Efficacy of pregabalin in generalized social anxiety disorder: results of a double-blind, placebo-controlled, fixed-dose study.
Feltner DE; Liu-Dumaw M; Schweizer E; Bielski R
Int Clin Psychopharmacol; 2011 Jul; 26(4):213-20. PubMed ID: 21368587
[TBL] [Abstract][Full Text] [Related]
2. Pregabalin for treatment of generalized anxiety disorder: a 4-week, multicenter, double-blind, placebo-controlled trial of pregabalin and alprazolam.
Rickels K; Pollack MH; Feltner DE; Lydiard RB; Zimbroff DL; Bielski RJ; Tobias K; Brock JD; Zornberg GL; Pande AC
Arch Gen Psychiatry; 2005 Sep; 62(9):1022-30. PubMed ID: 16143734
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of pregabalin in preventing relapse in patients with generalized social anxiety disorder: results of a double-blind, placebo-controlled 26-week study.
Greist JH; Liu-Dumaw M; Schweizer E; Feltner D
Int Clin Psychopharmacol; 2011 Sep; 26(5):243-51. PubMed ID: 21734588
[TBL] [Abstract][Full Text] [Related]
4. Pregabalin in generalized anxiety disorder: a placebo-controlled trial.
Pande AC; Crockatt JG; Feltner DE; Janney CA; Smith WT; Weisler R; Londborg PD; Bielski RJ; Zimbroff DL; Davidson JR; Liu-Dumaw M
Am J Psychiatry; 2003 Mar; 160(3):533-40. PubMed ID: 12611835
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and tolerability of pregabalin using a flexible, optimized dose schedule in Korean patients with peripheral neuropathic pain: a 10-week, randomized, double-blind, placebo-controlled, multicenter study.
Moon DE; Lee DI; Lee SC; Song SO; Yoon DM; Yoon MH; Kim HK; Lee YW; Kim C; Lee PB
Clin Ther; 2010 Dec; 32(14):2370-85. PubMed ID: 21353106
[TBL] [Abstract][Full Text] [Related]
6. Long-term efficacy of pregabalin in generalized anxiety disorder.
Feltner D; Wittchen HU; Kavoussi R; Brock J; Baldinetti F; Pande AC
Int Clin Psychopharmacol; 2008 Jan; 23(1):18-28. PubMed ID: 18090504
[TBL] [Abstract][Full Text] [Related]
7. A randomized, double-blind, placebo-controlled, fixed-dose, multicenter study of pregabalin in patients with generalized anxiety disorder.
Feltner DE; Crockatt JG; Dubovsky SJ; Cohn CK; Shrivastava RK; Targum SD; Liu-Dumaw M; Carter CM; Pande AC
J Clin Psychopharmacol; 2003 Jun; 23(3):240-9. PubMed ID: 12826986
[TBL] [Abstract][Full Text] [Related]
8. Early onset anxiolytic efficacy after a single dose of pregabalin: double-blind, placebo- and active-comparator controlled evaluation using a dental anxiety model.
Nutt D; Mandel F; Baldinetti F
J Psychopharmacol; 2009 Nov; 23(8):867-73. PubMed ID: 18635690
[TBL] [Abstract][Full Text] [Related]
9. Switching from long-term benzodiazepine therapy to pregabalin in patients with generalized anxiety disorder: a double-blind, placebo-controlled trial.
Hadley SJ; Mandel FS; Schweizer E
J Psychopharmacol; 2012 Apr; 26(4):461-70. PubMed ID: 21693549
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of pregabalin for peripheral neuropathic pain: results of an 8-week, flexible-dose, double-blind, placebo-controlled study conducted in China.
Guan Y; Ding X; Cheng Y; Fan D; Tan L; Wang Y; Zhao Z; Hong Z; Zhou D; Pan X; Chen S; Martin A; Tang H; Cui L
Clin Ther; 2011 Feb; 33(2):159-66. PubMed ID: 21444113
[TBL] [Abstract][Full Text] [Related]
11. Long-term treatment of anxiety disorders with pregabalin: a 1 year open-label study of safety and tolerability.
Montgomery S; Emir B; Haswell H; Prieto R
Curr Med Res Opin; 2013 Oct; 29(10):1223-30. PubMed ID: 23808960
[TBL] [Abstract][Full Text] [Related]
12. How well do randomized controlled trial data generalize to 'real-world' clinical practice settings? A comparison of two generalized anxiety disorder studies.
Kasper S; Brasser M; Schweizer E; Lyndon G; Prieto R
Eur Neuropsychopharmacol; 2014 Jan; 24(1):125-32. PubMed ID: 24290532
[TBL] [Abstract][Full Text] [Related]
13. The efficacy of pregabalin and benzodiazepines in generalized anxiety disorder presenting with high levels of insomnia.
Montgomery SA; Herman BK; Schweizer E; Mandel FS
Int Clin Psychopharmacol; 2009 Jul; 24(4):214-22. PubMed ID: 19542983
[TBL] [Abstract][Full Text] [Related]
14. An international, randomized, double-blind, placebo-controlled, phase III trial of pregabalin monotherapy in treatment of patients with fibromyalgia.
Pauer L; Winkelmann A; Arsenault P; Jespersen A; Whelan L; Atkinson G; Leon T; Zeiher B;
J Rheumatol; 2011 Dec; 38(12):2643-52. PubMed ID: 21965636
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of pregabalin in the treatment of generalized anxiety disorder: a 6-week, multicenter, randomized, double-blind, placebo-controlled comparison of pregabalin and venlafaxine.
Montgomery SA; Tobias K; Zornberg GL; Kasper S; Pande AC
J Clin Psychiatry; 2006 May; 67(5):771-82. PubMed ID: 16841627
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of the novel anxiolytic pregabalin in social anxiety disorder: a placebo-controlled, multicenter study.
Pande AC; Feltner DE; Jefferson JW; Davidson JR; Pollack M; Stein MB; Lydiard RB; Futterer R; Robinson P; Slomkowski M; DuBoff E; Phelps M; Janney CA; Werth JL
J Clin Psychopharmacol; 2004 Apr; 24(2):141-9. PubMed ID: 15206660
[TBL] [Abstract][Full Text] [Related]
17. Impact of gastrointestinal symptoms on response to pregabalin in generalized anxiety disorder: results of a six-study combined analysis.
Stein DJ; Bruce Lydiard R; Herman BK; Mandel FS
Int Clin Psychopharmacol; 2009 May; 24(3):126-32. PubMed ID: 19352198
[TBL] [Abstract][Full Text] [Related]
18. The vasopressin V(1b) receptor antagonist SSR149415 in the treatment of major depressive and generalized anxiety disorders: results from 4 randomized, double-blind, placebo-controlled studies.
Griebel G; Beeské S; Stahl SM
J Clin Psychiatry; 2012 Nov; 73(11):1403-11. PubMed ID: 23146246
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and tolerability of extended release quetiapine fumarate monotherapy in the acute treatment of generalized anxiety disorder: a randomized, placebo controlled and active-controlled study.
Merideth C; Cutler AJ; She F; Eriksson H
Int Clin Psychopharmacol; 2012 Jan; 27(1):40-54. PubMed ID: 22045039
[TBL] [Abstract][Full Text] [Related]
20. A 14-week, randomized, double-blinded, placebo-controlled monotherapy trial of pregabalin in patients with fibromyalgia.
Arnold LM; Russell IJ; Diri EW; Duan WR; Young JP; Sharma U; Martin SA; Barrett JA; Haig G
J Pain; 2008 Sep; 9(9):792-805. PubMed ID: 18524684
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
